@Article{,
AUTHOR = {G. Steinhoff, B. Ittah, S. Rowan},
TITLE = {The efficacy of chondroitin sulfate 0.2% in treating interstitial cystitis},
JOURNAL = {Canadian Journal of Urology},
VOLUME = {9},
YEAR = {2002},
NUMBER = {1},
PAGES = {1454--1458},
URL = {http://www.techscience.com/CJU/v9n1/63400},
ISSN = {1488-5581},
ABSTRACT = {<b>Objective:</b> An open label study of chondroitin sulfate was undertaken to determine the response of patients with interstitial cystitis and positive potassium test results to this agent.<br/>
<b>Method:</b> Eighteen patients with classic features of interstitial cystitis were enrolled in the study. Patients received 40 mL chondroitin sulfate, 0.2% instilled intravesically once a week for four weeks and then once a month for 12 months. At the same times, Quality of Life Improvement scores, voiding diaries, and pain and voiding indices were reviewed.<br/>
<b>Results:</b> Thirteen of 18 patients were followed for the entire 13-month study. Twelve of these patients responded to treatment within 3 to 12 weeks, on average. A total of 6/13 (46.2%) showed a good response, 2/13 (15.4%) had a fair response, and 4/13 (30.8%) had a partial response and 1/13 (7.7%) showed no response.<br/>
<b>Conclusion:</b> Intravesical chondroitin sulfate seems to demonstrate some beneficial effects in treatment of interstitial cystitis patients who have positive potassium stimulation test results.},
DOI = {}
}